Meghmani Organics Ltd Q1 FY26 Results & Concall Highlights: Revenue, Margins & Order Book
Published 19 Jul 2026 | Fertilizers & Agrochemicals | Market Cap: ₹1.6K Cr
Meghmani Organics anticipates double-digit growth in the crop protection segment for the next 2-3 years. Meghmani Organics targets double-digit revenue growth, aiming for 15%-20% top-line growth over the next few years, particularly in crop protection.
From Meghmani Organics Ltd's Q1 FY26 earnings-call transcript · updated 23 Aug 2026.
Price
₹60.3
Market Cap
₹1.6K Cr
P/E Ratio
25.0
How does Meghmani Organics Ltd rank in Fertilizers & Agrochemicals?
Compare Meghmani Organics Ltd against every Fertilizers & Agrochemicals company this quarter on revenue, margins and earnings-call signals.
Meghmani Organics Ltd — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest: revenue ₹474 Cr, net profit ₹8 Cr.
Full financials →📊 Revenue & Sales Performance
- →Meghmani Organics anticipates double-digit growth in the crop protection segment for the next 2-3 years.
- →For FY '26, the company aims for 15-20% growth in top-line, although maintaining a consistent 20% growth may be challenging as base grows.
- →Growth drivers include a shift towards high-value, new generation products manufactured in the multipurpose plant.
- →Expansion into new geographies and increased registrations in various markets are expected to fuel growth.
- →Utilization in crop protection plants is currently around 76-77%; growth will be driven by higher-value products and increased conversion into formulations.
- →Nano Urea product segment expects double-digit growth.
- →Titanium dioxide division has potential for further growth as utilization improves and operating leverage kicks in.
- →Overall, the company foresees maintaining a double-digit CAGR for the next 3 years, backed by diversified global presence and product innovation.
📈 Profitability & Margins
- →Meghmani Organics targets double-digit revenue growth, aiming for 15%-20% top-line growth over the next few years, particularly in crop protection.
- →Q1 FY26 saw 20% growth, but sustaining such high growth as the base grows will be challenging.
- →Management is optimistic about maintaining double-digit EBITDA margins, with crop protection margins around 17% this quarter as a benchmark.
- →Profitability focus remains strong, but exact margin forecasts for FY26 are uncertain due to market variables.
- →Nano Urea segment expects double-digit growth following registrations in 7 countries.
- →Growth will be driven by higher-value new generation products from the multipurpose plant (MPP) and increased formulation capacity utilization.
- →Inventory and raw material costs are stable, with potential raw material cost increases possibly passed on to customers with a positive margin impact.
- →Overall, earnings growth is expected alongside stable to improving operating margins, subject to external market conditions.
🏗️ Capital Expenditure Plans
- →Meghmani Organics has completed recent capex with no new capex capitalized in the latest quarter; depreciation remains stable as a result.
- →No further capex planned currently; depreciation expected to remain at the current level going forward.
- →Focus is on better utilization of existing multipurpose plant (MPP) capacity, which is at ~76%-77% utilization.
- →Growth is driven by high-value new-generation products manufactured in the multipurpose plant, enabling revenue growth without major capex.
- →Plans exist to ramp up titanium dioxide plant capacity and improve realization; detailed updates expected by Q3.
- →Strategic focus on product registrations, especially in the Brazil market, with over 40 registrations (6 approved, 30+ in pipeline) to drive growth.
- →Emphasis on building a solid supply chain and expanding product portfolio rather than heavy capital investments at present.
💰 Fundraising & Capital Structure
- →There is no mention of any ongoing or planned new fundraising through debt or equity in the provided transcript.
- →Management stated that there is no further capital expenditure (capex) planned; all recent capex has been capitalized.
- →Depreciation levels are expected to remain stable, indicating no major new asset additions funded by new borrowing.
- →Finance costs have increased due to currency fluctuations, but no new borrowing or fund raising plans were indicated.
- →Overall, the discussion suggests that the company plans to achieve growth through existing capacities and product mix improvements without additional fundraising.
📋 Order Book & Pipeline
Key Metrics
Continue your research
What Meghmani Organi.'s management said in earlier quarters
Others in Fertilizers & Agrochemicals this season
- Krishana Phosch. (Q1 FY26)
Production capacity is currently utilized at around 81%, with plans to ramp up utilization post new plant commissioning. Key concall takeaways from Krishana…
- Sharda Cropchem (Q1 FY26)
In Q1 FY 2026, revenue grew 25% year-on-year to Rs. Key concall takeaways from Sharda Cropchem Ltd's Q1 FY26 earnings call — and how it ranks against sector…
- UPL Ltd (Q1 FY26)
India crop protection (UPL SAS) saw strong 13% revenue growth in Q1 driven by 9% volume growth and 4% pricing improvement (Page 11). Key concall takeaways from…
- Rallis India (Q1 FY26)
CSM business is long-term and ongoing with some large opportunities still to be secured (not yet cracked INR 500 crore opportunity). Key concall takeaways from…
Frequently Asked Questions
What were Meghmani Organics Ltd Q1 FY26 results?
Meghmani Organics anticipates double-digit growth in the crop protection segment for the next 2-3 years. Meghmani Organics targets double-digit revenue growth, aiming for 15%-20% top-line growth over the next few years, particularly in crop protection.
What is Meghmani Organics Ltd share price analysis?
Meghmani Organics Ltd currently shows a neutral. The stock trades at a P/E of 25.0 with a market cap of ₹1,608 Cr. Investors should review the full earnings analysis for detailed insights.
Is Meghmani Organics Ltd planning capital expenditure?
Meghmani Organics has completed recent capex with no new capex capitalized in the latest quarter; depreciation remains stable as a result.
Keep Meghmani Organics Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.